Martin Dræbye Gantzhorn, head of Horten's Life Science and Healthcare, has been appointed as a member of Dansk Biotek’s Expert Committee. The Expert Committee consists of lawyers and patent attorneys with expertise within the Life Science and Healthcare sector.
The Committee organizes dialogue meetings for its members, offering members the chance of sparring with the Committee’s members advice on legal and patent matters of relevance to the biotech industry – e.g. due diligence, patents and co-operation with public research institutions.
DANSK BIOTEK is the industry association for 150 Danish companies, that develop new drug candidates or innovative and industrial solutions.